"Clinical Research for many disease categories. Osteoporosis diagnosis and treatment."

During the past decade, New Mexico Clinical Research & Osteoporosis Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 19 clinical trials were completed, i.e. on average, 105.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 11 clinical trials were completed. i.e. 157.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Mexico Clinical Research & Osteoporosis Center" #1 sponsor was "Pfizer" with 9 trials, followed by "Mannkind Corporation" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "Shire" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Mexico Clinical Research & Osteoporosis Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Mereo BioPharma" with 2 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "New Mexico Clinical Research & Osteoporosis Center" are "Osteoporosis" (9 trials), "Osteoarthritis" (4 trials), "Arthritis" (3 trials), "Eosinophilic Esophagitis" (3 trials) and "Osteoarthritis, Hip" (3 trials). Many other conditions were trialed in "New Mexico Clinical Research & Osteoporosis Center" in a lesser frequency.

Most popular intervention types in "New Mexico Clinical Research & Osteoporosis Center" are "Drug" (37 trials), "Biological" (10 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "placebo" (4 trials), "Zoledronic Acid" (3 trials), "tanezumab" (3 trials) and "CC-93538" (2 trials). Other intervention names were less common.

The vast majority of trials in "New Mexico Clinical Research & Osteoporosis Center" are 33 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "New Mexico Clinical Research & Osteoporosis Center". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in New Mexico Clinical Research & Osteoporosis Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in New Mexico Clinical Research & Osteoporosis Center, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".